Chimeric antigen receptor (CAR) T-cell therapy is a treatment option for patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) after first-line treatment and who are ineligible for autologous hematopoietic cell…
Please enable JavaScript if it is disabled in your browser or access the information through the links provided below.
The FDA has granted fast track designation to the novel immunotherapy EO2463 for the treatment of follicular lymphoma, backed by positive interim data from the ongoing phase 2 SIDNEY trial (NCT04669171).1
Under this fast track designation,…
About Qnity
Qnity, DuPont’s Electronics business, is a premier technology solutions provider across the semiconductor value chain, empowering AI, high performance computing, and advanced connectivity. From groundbreaking solutions for…
Marsh’s Trade Credit Report 2025 discusses the UK’s trade credit landscape in detail.
Despite many businesses increasingly exposing themselves to greater risk…
Paris, France (October 16, 2025 – 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the third quarter of 2025 reached Euro 6,867 million, representing a year-on-year increase of 11.7% at constant exchange rates1 compared…
(Alliance News) – Mila Resources PLC said on Thursday it has completed diamond drilling at the Yarrol project in Queensland, Australia.
The London-based post-discovery gold exploration firm said samples are currently being prepared for…
A new analysis by the chief economist finds that the extraordinary tax benefits on the funds are regressive, and cost the public purse over NIS 10 billion annually.
The combination of teclistamab-cqyv (Tecvayli) and daratumumab and hyaluronidase-fihj (subcutaneous daratumumab; Darzalex Faspro) demonstrated an improvement in progression-free survival (PFS) and overall survival (OS) compared with subcutaneous…